E
Bright Minds Biosciences Inc. DRUG
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -14.46% -35.42% -29.56% -34.25% -29.65%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -61.83% -63.97% -61.01% -49.64% -48.70%
Operating Income 61.83% 63.97% 61.01% 49.64% 48.70%
Income Before Tax 84.28% 62.35% 59.86% 48.76% 48.22%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 84.28% 62.35% 59.86% 48.76% 48.22%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 84.28% 62.35% 59.86% 48.76% 48.22%
EBIT 61.83% 63.97% 61.01% 49.64% 48.70%
EBITDA -- -- -- -- --
EPS Basic 86.49% 65.63% 65.55% 60.90% 64.26%
Normalized Basic EPS 86.50% 65.63% 65.54% 60.89% 64.25%
EPS Diluted 86.33% 65.43% 65.48% 60.72% 64.16%
Normalized Diluted EPS 86.36% 65.53% 65.47% 60.89% 64.25%
Average Basic Shares Outstanding 28.95% 15.59% 18.86% 26.62% 36.70%
Average Diluted Shares Outstanding 33.31% 16.83% 20.19% 26.62% 36.70%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings